MediRox AB operates in the Diagnostic substances sector.
In addition to historical fundamental analyses, the complete report available to purchase compares MediRox AB with three other
pharmaceutical manufacturers in Europe:
IDL Biotech AB
sales of 28.52 million Swedish Kronor [US$3.19 million]
(2.08 million Euro [US$2.21 million]
of which 75%
was Product sales (own and third party)), and
based in Finland
(6.05 million Euro [US$6.43 million]
MediRox AB reported sales of SEK 33.86 million (US$3.78 million)
December of 2015.
increase of 9.6%
versus 2014, when the company's sales were SEK 30.90 million.
This was the third consecutive year of growth at MediRox AB.